Peel Hunt Reiterates “Buy” Rating for CVS Group (CVSG)

CVS Group (LON:CVSG)‘s stock had its “buy” rating reaffirmed by analysts at Peel Hunt in a report released on Thursday. They presently have a GBX 1,350 ($18.96) price objective on the stock. Peel Hunt’s target price suggests a potential upside of 9.14% from the company’s current price.

Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 1,450 ($20.36) price target on shares of CVS Group in a report on Thursday, November 30th.

Shares of CVS Group (LON CVSG) opened at GBX 1,237 ($17.37) on Thursday. CVS Group has a 52-week low of GBX 13.22 ($0.19) and a 52-week high of GBX 1,500 ($21.06). The stock has a market cap of $798.07 and a price-to-earnings ratio of 6,872.22.

In other news, insider Richard A. Connell purchased 2,061 shares of the stock in a transaction that occurred on Thursday, December 7th. The stock was acquired at an average cost of GBX 920 ($12.92) per share, with a total value of £18,961.20 ($26,627.16).

WARNING: “Peel Hunt Reiterates “Buy” Rating for CVS Group (CVSG)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at

About CVS Group

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with's FREE daily email newsletter.

Leave a Reply